Has worked in medical product development and commercialization for 25 years and in vaccine product development since 2012.  At Vaxxas, Angus has overall responsibility for R&D and leads the company’s vaccine development programs, including leading multiple Phase I studies in Australia. His areas of experience include clinical operations, CMC (formulation / analytical development), medical device design / development, quality and risk management. Prior to Vaxxas, he worked as a life sciences consultant and commenced his career with GlaxoSmithKline (UK) within pharmaceutical development of new chemical entities. Angus has Ph.D. in Pharmaceutics and undergraduate qualification in Pharmacy from the University of Otago, New Zealand.